Copyright
©The Author(s) 2017.
World J Gastroenterol. Dec 14, 2017; 23(46): 8235-8247
Published online Dec 14, 2017. doi: 10.3748/wjg.v23.i46.8235
Published online Dec 14, 2017. doi: 10.3748/wjg.v23.i46.8235
FC ≥ 250 μg/g | CRP ≥ 5 mg/L | ESR ≥ 10 mm/h | |
Colonic or ileum-colonic CD (%) | |||
Sensitivity | 93 | 46.2 | 61.5 |
Specificity | 70 | 83.3 | 66.7 |
PPV | 68.4 | 75.0 | 53.3 |
NPV | 93.3 | 73.1 | 73.7 |
AUC | 0.91 | 0.76 | 0.71 |
P value | < 0.001 | 0.011 | 0.042 |
UC | |||
Sensitivity | 84.6 | 23.1 | 46.2 |
Specificity | 100 | 100 | 83.3 |
PPV | 100 | 100 | 75.0 |
NPV | 85.7 | 54.5 | 58.8 |
AUC | 0.96 | 0.84 | 0.76 |
P value | < 0.001 | 0.004 | 0.028 |
- Citation: Chen JM, Liu T, Gao S, Tong XD, Deng FH, Nie B. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China. World J Gastroenterol 2017; 23(46): 8235-8247
- URL: https://www.wjgnet.com/1007-9327/full/v23/i46/8235.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i46.8235